Colinz Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 531210 | NSE: | Pharmaceuticals & Drugs | Small Cap

Colinz Laboratories Share Price

54.30 -2.85 -4.99%
as on 07-Oct'24 16:01

DeciZen - make an informed investing decision on Colinz Laboratories

M-Cap below 100cr DeciZen not available

Colinz Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
28.91
Market Cap:
14.4 Cr.
52-wk low:
35.2
52-wk high:
84.4

Is Colinz Laboratories Ltd an attractive stock to invest in?

1. Is Colinz Laboratories Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Colinz Laboratories Ltd is a average quality company.

2. Is Colinz Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Colinz Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Colinz Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Colinz Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Colinz Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Colinz Laboratories Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 3.1%3.3%3.1%3.3%3.5%3.3%4.3%6.8%7.9%7.7%-
Value Creation
Index
-0.8-0.8-0.8-0.8-0.8-0.8-0.7-0.5-0.4-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 7.98.18.17.97.67.56.177.277
Sales YoY Gr.-2.7%-0.6%-1.9%-4.1%-0.5%-19%13.8%2.9%-1.7%-
Adj EPS 0.30.30.40.70.30.40.50.71.91.92
YoY Gr.--3.6%48.2%62.5%-47.7%8.8%21.6%64.4%154.1%2.7%-
BVPS (₹) 17.417.718.419.119.319.320.621.732.335.536.1
Adj Net
Profit
0.10.10.10.20.10.10.20.30.50.50
Cash Flow from Ops. 0.10.60.10.30.10.62.20.50.41-
Debt/CF from Ops. 24.62.813.31.35.80.70.510.70.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -1.3%-1.5%4.8%-1.7%
Adj EPS 23.9%41.5%62.5%2.7%
BVPS8.3%13%20%9.9%
Share Price 27.6% 42.2% 34.6% 43.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
1.61.52.23.51.81.92.94.565.75.5
Op. Profit
Mgn %
5.85.65.14.54.645.48.48.87.78
Net Profit
Mgn %
1.31.21.82.91.61.73.44.96.66.97.3
Debt to
Equity
0.40.30.10.10.10.10.10.100.1-
Working Cap
Days
227226226224220198195130110101228
Cash Conv.
Cycle
114122136137145143135897359169

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 5.50%

Net Profit is growing at healthy rate in last 3 years 62.47%

Sales growth has been subdued in last 3 years 4.79%

Sales growth is not so good in last 4 quarters at -4.53%

Latest Financials - Colinz Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 2 -
TTM Sales (₹ Cr.) 6.9 -
BVPS (₹.) 36.1 -
Reserves (₹ Cr.) 7 -
P/BV 1.58 -
PE 28.91 -
From the Market
52 Week Low / High (₹) 35.20 / 84.40
All Time Low / High (₹) 0.25 / 84.40
Market Cap (₹ Cr.) 14.4
Equity (₹ Cr.) 2.5
Face Value (₹) 10
Industry PE 47.6

Management X-Ray of Colinz Laboratories:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Colinz Laboratories

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales7.898.108.057.907.587.546.116.957.157.03
Operating Expenses 7.447.647.647.547.237.235.786.366.556.49
Manufacturing Costs0.190.200.200.350.160.150.200.180.190.19
Material Costs3.373.482.942.732.802.742.182.302.292.31
Employee Cost 2.772.862.913.153.073.252.392.772.902.79
Other Costs 1.121.091.581.311.201.0811.111.171.19
Operating Profit 0.450.450.410.360.350.300.330.590.610.54
Operating Profit Margin (%) 5.7%5.6%5.1%4.5%4.6%4.0%5.4%8.4%8.5%7.7%
Other Income 0.110.100.090.100.120.130.190.170.170.28
Interest 0.120.120.120.080.100.070.090.080.050.04
Depreciation 0.300.280.270.220.220.190.190.200.130.13
Exceptional Items 0000000000
Profit Before Tax 0.150.150.120.150.160.180.250.480.600.65
Tax 0.050.06-0.02-0.080.030.050.040.140.140.16
Profit After Tax 0.100.090.140.230.120.130.210.340.460.49
PAT Margin (%) 1.2%1.2%1.8%2.9%1.6%1.7%3.4%4.9%6.4%6.9%
Adjusted EPS (₹)0.30.30.40.70.30.40.61.01.81.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 6.166.266.526.756.846.847.297.698.148.95
Share Capital 3.543.543.543.543.543.543.553.552.522.52
Reserves 2.622.712.983.213.303.293.754.145.626.43
Minority Interest0000000000
Debt2.331.600.760.420.680.380.990.480.270.57
Long Term Debt2.331.6000000000
Short Term Debt000.760.420.680.380.990.480.270.57
Trade Payables1.070.580.450.680.340.370.540.480.650.60
Others Liabilities 1.101.321.941.741.311.221.271.281.161.24
Total Liabilities 10.669.759.679.599.178.8110.109.9310.2311.36

Fixed Assets

Gross Block6.646.646.666.666.676.726.886.916.176.17
Accumulated Depreciation3.483.764.034.254.464.664.855.054.464.60
Net Fixed Assets3.162.882.632.412.212.062.031.861.711.58
CWIP 0000000000
Investments 0.290.290.410.530.500.360.610.670.661.02
Inventories2.662.222.161.971.901.691.250.930.940.85
Trade Receivables1.351.351.471.681.681.491.301.211.130.86
Cash Equivalents 1.781.621.631.871.992.604.685.215.737
Others Assets1.431.401.371.130.900.610.250.060.060.05
Total Assets 10.669.759.679.599.178.8110.109.9310.2311.36

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0.090.580.060.340.120.582.160.470.401.03
PBT 0.150.150.120.150.160.180.250.480.600.65
Adjustment 0.300.280.290.210.190.130.110.110.03-0.11
Changes in Working Capital -0.320.17-0.330.01-0.210.341.880.03-0.070.67
Tax Paid -0.03-0.03-0.03-0.03-0.03-0.07-0.08-0.15-0.16-0.18
Cash Flow From Investing Activity 0.030-0.01-0.11-0.01-0.04-0.15-0.030.010.01
Capex 00-0.0200-0.04-0.16-0.0400
Net Investments 0.0300-0.11-0.0100000
Others 000000.0100.010.010.01
Cash Flow From Financing Activity 0.45-0.73-0.030.010.020.060.080.090.110.23
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.45-0.7300000000
Interest Paid 00-0.03-0.08-0.10-0.07-0.09-0.08-0.05-0.04
Dividend Paid 0000000000
Others 0000.090.120.130.170.170.160.27
Net Cash Flow 0.57-0.160.020.240.120.602.080.520.521.27
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)1.551.522.213.481.791.912.944.535.785.7
ROCE (%)3.123.273.123.253.453.34.286.767.867.67
Asset Turnover Ratio0.80.820.830.830.820.850.650.70.710.65
PAT to CFO Conversion(x)0.96.440.431.4814.4610.291.380.872.1
Working Capital Days
Receivable Days60596472807683666052
Inventory Days971069995928687574846
Payable Days104866475664776819099

Colinz Laboratories Ltd Stock News

Colinz Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Colinz Laboratories on 07-Oct-2024 16:01 is ₹54.30.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-Oct-2024 16:01 the market cap of Colinz Laboratories stood at ₹14.40.
The latest P/E ratio of Colinz Laboratories as of 07-Oct-2024 16:01 is 28.91.
The latest P/B ratio of Colinz Laboratories as of 07-Oct-2024 16:01 is 1.58.
The 52-week high of Colinz Laboratories is ₹84.40 and the 52-week low is ₹35.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Colinz Laboratories is ₹6.88 ( Cr.) .

About Colinz Laboratories Ltd

Colinz Laboratories was established in 1987, the company is having modern manufacturing facility near Mumbai. The company is equipped with a full fledged in house testing / quality control laboratory.

The company houses well experienced pharmacists / technical personnel in development dept / manufacturing and caters to an ethical promotion of specialty products in India.

The company is having a well experienced marketing team of over 300 personnels and is having expertise in turn key projects (Design, erection & commissioning of pharma formulation plants) Transfer of technical know how (Pilot Batch to Commercial productions).

Business area of the company spreads to:

Pharmaceutical Formulations (of all dosages forms)

  • Tablets
  • Capsules
  • Parenterals
  • Creams/ Ointments/Lotions
  • Dry Powder
  • Liquid Orals
  • Soft Gelatine Capsules

Therapeutic Segments

  • Anti Biotics & Anti Bacterials
  • Anti Hypertensives
  • Diuretics
  • Lipid lowering Agents (Cholestrole Reducers)
  • Anti Emetics etc.

Vetinary formulations

  • Feed mix
  • Bolus
  • Vitamins & Others

Nutraceuticals

  • Spirulina
  • Co enzyme Q10 
  • Clucosamine
  • Lecithin
  • Vitamins

Herbal Preparations

  • Pain Balm (Instant relief for all types of pain)
  • Anti Cold Rub 

Ayurvedic Skin Care Creams Treatment of

  • Pimples 
  • Fairness
  • Stretch Marks 
  • Cracks

Capsules/Tablets/ Creams/ Powders

  • Anti Piles
  • Laxatives
  • Anti Diabetic
  • Anti Hypertensive
  • Antacid
  • Vigour & Vitality
  • General Debility 

Contract Manufacturing & Technical Know How Product Development

- Product Development & Clinical Research - Technical know how for formulations  - Currently Manufacturing for Europeon & Japanese companies

Sourcing API& / Intermediates Turn key products 

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.